Multidisciplinary Hepatocellular Carcinoma Care

Hepatocellular Carcinoma (HCC) accounts for about 75% of primary liver cancers. HCC begins in liver cells known as hepatocytes and most often occurs in individuals whose liver has been damaged by Hepatitis B or C virus-infection, alcohol consumption, and non-alcoholic steatohepatitis. HCC typically occurs in older people and is more common in men.

Treatment tends to be multi-modal when HCC is considered loco-regional, which often includes interventional radiology and surgical interventions. Because of the frequency of liver comorbidities in patients with HCC and the complexity of managing care using multiple modalities, a multidisciplinary approach is critical.

Featured Publications

Multidisciplinary HCC Care Effective Practices in Care Coordination

This report highlights effective practices in care coordination in action and provides valuable insights for cancer programs to consider. In 2019 findings from the Environmental Scan helped inform focus groups and interviews with three ACCC Member Programs exploring their effective practices in HCC care coordination.

Thank you to the following ACCC Cancer Program Member sites for their participation:

• Sharp HealthCare, San Diego, CA
• Mercy Medical Center, Baltimore, MD
• Emory Healthcare, Atlanta, GA

Download Report

Multidisciplinary Hepatocellular Carcinoma Care Environmental Scan

In collaboration with the American Cancer Society, Cancer Support Community, and Global Liver Institute, ACCC developed and launched a survey in 2018 to understand the perspectives and experiences of the multidisciplinary cancer team while caring for patients with hepatocellular carcinoma. Findings were used to inform the development of the Multidisciplinary Hepatocellular Carcinoma Care Environmental Scan, which highlights effective practices and challenges for managing HCC in community cancer programs.
Download

Building Multidisciplinary Care Capacity for People Impacted by Hepatocellular Carcinoma

Learn how multidisciplinary providers can optimize care for patients with hepatocellular carcinoma by building greater care capacity and improving coordination of clinical and supportive care services. Developed by ACCC and its partners—the American Cancer Society, Blue Faery: The Adrienne Wilson Liver Cancer Association, Cancer Support Community, and Global Liver Institute—and with support by Bristol Myers Squibb and Eisai, this article highlights the efforts of a multi-year program to build multidisciplinary care capacity.

Download Article

Abstracts & Presentations

For more information on this project, please contact the ACCC Provider Education department.